Login

WANdisco's partnership with IBM uniquely enables the active replication of data across hybrid, cloud, and on-premises environments.|David Richards, CEO of WANdisco PLC 00:10:00

Share On Facebook Share On Twitter

David Richards, CEO of WANdisco PLC

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Bill Gates champions big ideas on digitalization and clean energy, focusing on technology-driven solutions to address global challenges like climate change and sustainability.
00:10:00
Q1 2024 Market Review: Strong Returns, Persistent Inflation, and Federal Reserve Outlook
00:10:00
Based on proprietary heparin technology Corline Biomedical develops Renaparin to improve kidney transplantation|Henrik Nittmar, CEO,Corline Biomedical
00:10:00
The Art and Science of Investing: Insights from PFM Asset Management's Alex Gurvich on the Dakota Live! Podcast
00:10:00
Timberline Resources' Carlin-Style Eureka Project Hits High-Grade Gold Intersections
00:10:00
FPX Nickel Advances Massive Baptiste Deposit in British Columbia
00:10:00
Ibaera Capital: Funding Future-Facing Metals in Mining Projects
00:10:00
Drew McKnight, co-founder of Fortress Investment Group, contributes to financial discussions on CNBC LLC, covering various topics including financial advisors and options.|Drew McKnight, co-founder of Fortress Investment Group
00:10:00
Community building is crucial for crypto companies|Alex Felix,Managing Partner and Chief Investmen,t Officer,CoinFund
00:10:00
Accelerating Sustainability: Waste Plastic Upcycling Pioneers Expansion | Niels Stielund, Chairman, Wpu Waste Plastic Upcycling A/S.
00:10:00
Moonfare's Co-Investment Strategy: Capitalizing on Private Equity Opportunities
00:10:00
Investing With Intention In Venture Capital|Ajay Relan,Managing Partner,Slauson & Co

© 2017 - Neuhu+